Vol 15, No 2 (2018)
Date published: 2018-06-27
Table of Contents
open access
paid access
Nina Jolanta Ogińska-Bulik
Research paper
Paweł Jan Liśkiewicz, Justyna Pełka-Wysiecka, Michał Wroński, Agata Bąba-Kubiś, Jerzy Samochowiec
Review paper
Cariprazine — antipsychotic with partial dopaminergic agonist propeties
Przemysław Bieńkowski
Review paper
Duloxetine and venlafaxine ― SNRI the same or not?
Tomasz Tafliński
Review paper
The health effects of cannabis and cannabinoids
Anna Klimkiewicz, Agata Jasińska, Agata Jasińska
Review paper
Tools for the assessment of executive functions in patients suffering from schizophrenia
Anna Mosiołek, Aleksandra Mazurek, Jacek Gierus
Review paper
„Legal highs” — what we know about novel psychoactive substances?
Bogumiła Lubecka, Marek Lubecki, Robert Pudlo
Review paper
Telemedical cognitive-behavioral therapy
Marek Krzystanek, Aleksander Stolarczyk, Mariusz Borkowski, Sławomir Murawiec
Review paper
Psychiatria to misja. Wywiad z Doktorem Grzegorzem Goryszewskim, Prezesem Zarządu Grupy ALLENORT
Joanna Chatizow
Other materials agreed with the Editors